ZBIO ▲ +0.1% - Zenas BioPharma, Inc.
$ZBIO - Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026
07-OCT-2026 07:05 AM ET
Share this post
More filings for $ZBIO
ZBIO ▼ -0.2% - Zenas BioPharma, Inc.Sep 22, 2026ZBIO ▼ -1.6% - Zenas BioPharma, Inc.Sep 18, 2026ZBIO - Zenas BioPharma, Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026ZBIO - Zenas BioPharma, Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026ZBIO ▼ -0.7% - Zenas BioPharma, Inc.Sep 4, 2026ZBIO - Zenas BioPharma, Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 19, 2026
View full $ZBIO filing history →💬 Comments
Loading comments…
Leave a comment